Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biol Chem ; 288(36): 26052-26066, 2013 Sep 06.
Artigo em Inglês | MEDLINE | ID: mdl-23880767

RESUMO

ß-Glucosidase 2 (GBA2) is an enzyme that cleaves the membrane lipid glucosylceramide into glucose and ceramide. The GBA2 gene is mutated in genetic neurological diseases (hereditary spastic paraplegia and cerebellar ataxia). Pharmacologically, GBA2 is reversibly inhibited by alkylated imino sugars that are in clinical use or are being developed for this purpose. We have addressed the ambiguity surrounding one of the defining characteristics of GBA2, which is its sensitivity to inhibition by conduritol B epoxide (CBE). We found that CBE inhibited GBA2, in vitro and in live cells, in a time-dependent fashion, which is typical for mechanism-based enzyme inactivators. Compared with the well characterized impact of CBE on the lysosomal glucosylceramide-degrading enzyme (glucocerebrosidase, GBA), CBE inactivated GBA2 less efficiently, due to a lower affinity for this enzyme (higher KI) and a lower rate of enzyme inactivation (k(inact)). In contrast to CBE, N-butyldeoxygalactonojirimycin exclusively inhibited GBA2. Accordingly, we propose to redefine GBA2 activity as the ß-glucosidase that is sensitive to inhibition by N-butyldeoxygalactonojirimycin. Revised as such, GBA2 activity 1) was optimal at pH 5.5-6.0; 2) accounted for a much higher proportion of detergent-independent membrane-associated ß-glucosidase activity; 3) was more variable among mouse tissues and neuroblastoma and monocyte cell lines; and 4) was more sensitive to inhibition by N-butyldeoxynojirimycin (miglustat, Zavesca®), in comparison with earlier studies. Our evaluation of GBA2 makes it possible to assess its activity more accurately, which will be helpful in analyzing its physiological roles and involvement in disease and in the pharmacological profiling of monosaccharide mimetics.


Assuntos
1-Desoxinojirimicina/análogos & derivados , Inibidores Enzimáticos/farmacocinética , Inositol/análogos & derivados , beta-Glucosidase/antagonistas & inibidores , 1-Desoxinojirimicina/farmacocinética , 1-Desoxinojirimicina/farmacologia , Animais , Células COS , Linhagem Celular Tumoral , Ataxia Cerebelar/tratamento farmacológico , Ataxia Cerebelar/enzimologia , Chlorocebus aethiops , Inibidores Enzimáticos/farmacologia , Glucosilceramidase , Humanos , Concentração de Íons de Hidrogênio , Inositol/farmacocinética , Inositol/farmacologia , Camundongos , Paraplegia Espástica Hereditária/tratamento farmacológico , Paraplegia Espástica Hereditária/enzimologia , beta-Glucosidase/metabolismo
2.
Int J Neuropsychopharmacol ; 15(4): 485-96, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-21557885

RESUMO

There is good evidence that forebrain serotonergic systems modulate cognitive flexibility. Latent inhibition (LI) is a cross-species phenomenon which manifests as poor conditioning to a stimulus that has previously been experienced without consequence and is widely considered an index of the ability to ignore irrelevant stimuli. While much research has focused on dopaminergic mechanisms underlying LI, there is also considerable evidence of serotonergic modulation. However, the neuroanatomical locus of these effects remains poorly understood. Previous work has identified the nucleus accumbens (NAc) as a key component of the neural circuit underpinning LI and furthermore, this work has shown that the core and shell subregions of the NAc contribute differentially to the expression of LI. To examine the role of the serotonergic input to NAc in LI, we tested animals with 5,7-dihydroxytryptamine (5,7-DHT) lesions to the core and shell subregions on LI assessed under experimental conditions that produce LI in shams and subsequently with weak stimulus pre-exposure designed to prevent the emergence of LI in shams. We found that serotonergic deafferentation of the core disrupted LI whereas 5,7-DHT lesions to the shell produced the opposite effect and potentiated LI.


Assuntos
5,7-Di-Hidroxitriptamina/toxicidade , Condicionamento Psicológico/fisiologia , Núcleo Accumbens/lesões , Núcleo Accumbens/fisiologia , Serotoninérgicos/toxicidade , Ácido 3,4-Di-Hidroxifenilacético/metabolismo , Estimulação Acústica , Animais , Cromatografia Líquida de Alta Pressão , Condicionamento Psicológico/efeitos dos fármacos , Dopamina/metabolismo , Inibidores da Captação de Dopamina/farmacologia , Eletroquímica , Ácido Hidroxi-Indolacético/metabolismo , Inibição Psicológica , Luz , Masculino , Piperazinas/farmacologia , Ratos , Ratos Wistar , Serotonina/metabolismo , Privação de Água
3.
Int J Neuropsychopharmacol ; 15(10): 1513-23, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22176724

RESUMO

Latent inhibition (LI) manifests as poorer conditioning to a stimulus that has previously been experienced without consequence. There is good evidence of dopaminergic modulation of LI, as the effect is reliably disrupted by the indirect dopamine (DA) agonist amphetamine. The disruptive effects of amphetamine on LI are reversed by both typical and atypical antipsychotics, which on their own are able to facilitate LI. However, the contribution of different DA receptors to these effects is poorly understood. Amphetamine effects on another stimulus selection procedure, overshadowing, have been suggested to be D1-mediated. Thus, in the current experiments, we systematically investigated the role of D1 receptors in LI. First, we tested the ability of the full D1 agonist SKF 81297 to abolish LI and compared the effects of this drug on LI and overshadowing. Subsequently, we examined whether the D1 antagonist SCH 23390 can lead to the emergence of LI under conditions that do not produce the effect in normal animals (weak pre-exposure). Finally, we tested the ability of SCH 23390 to block amphetamine-induced disruption of LI. We found little evidence that direct stimulation of D1 receptors abolishes LI (although there was some attenuation of LI at 0.4 mg/kg SKF 81297). Similarly, SCH 23390 failed to enhance LI. However, SCH 23390 did block amphetamine-induced disruption of LI. These data indicate that, while LI may be unaffected by selective manipulation of activity at D1 receptors, the effects of amphetamine on LI are to some extent dependent on actions at D1 receptors.


Assuntos
Condicionamento Psicológico/fisiologia , Inibição Psicológica , Tempo de Reação/fisiologia , Receptores de Dopamina D1/antagonistas & inibidores , Receptores de Dopamina D1/fisiologia , Anfetamina/farmacologia , Animais , Benzazepinas/farmacologia , Condicionamento Psicológico/efeitos dos fármacos , Antagonistas de Dopamina/farmacologia , Relação Dose-Resposta a Droga , Masculino , Ratos , Ratos Wistar , Tempo de Reação/efeitos dos fármacos
4.
Behav Neurosci ; 125(3): 396-403, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21480692

RESUMO

There is good evidence that the medial prefrontal cortex (mPFC) is involved in different aspects of recognition memory. However, the mPFC is a heterogeneous structure, and the contribution of the prelimbic (PL) and infralimbic (IL) cortices to recognition memory has not been investigated. Similarly, the role of different neuromodulators within the mPFC in these processes is poorly understood. To this end, we tested animals with 6-hydroxydopamine (6-OHDA) lesions of the PL and IL mPFC on three tests of object recognition memory that required judgments about recency, object location, and object identity. In the recency task, lesions to both PL and IL severely impaired animals' ability to differentiate between old (earlier presented) and recently presented familiar objects. Relative to sham and PL animals, the IL lesion also disrupted performance on the object location task. However, both lesions left novel object recognition intact. These data confirm previous reports that the mPFC is not required for discriminations based on the relative familiarity of individual objects. However, these results demonstrate that catecholamines within the PL cortex are crucial for relative recency judgments and suggest a possible role for neural processing within the IL in the integration of information about object location.


Assuntos
Encéfalo/fisiologia , Catecolaminas/metabolismo , Discriminação Psicológica/fisiologia , Córtex Pré-Frontal/fisiologia , Reconhecimento Psicológico/fisiologia , Percepção Espacial/fisiologia , Transmissão Sináptica/fisiologia , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Discriminação Psicológica/efeitos dos fármacos , Masculino , Microinjeções , Oxidopamina/administração & dosagem , Oxidopamina/toxicidade , Córtex Pré-Frontal/efeitos dos fármacos , Córtex Pré-Frontal/metabolismo , Ratos , Ratos Wistar , Reconhecimento Psicológico/efeitos dos fármacos , Percepção Espacial/efeitos dos fármacos , Transmissão Sináptica/efeitos dos fármacos , Fatores de Tempo
5.
Behav Neurosci ; 124(6): 789-99, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21133535

RESUMO

There is increasing focus on the role of the nucleus accumbens (NAc) in learning and memory, but there is little consensus as to how the core and medial shell subregions of the NAc contribute to these processes. In the current experiments, we used spontaneous object recognition to test rats with 6-hydroxydopamine lesions targeted at the core or medial shell of the NAc on a familiarity discrimination task and a location discrimination task. In the object recognition variant, control animals were able to discriminate the novel object at both 24-hr and 5-min delay. However, in the lesion groups, performance was systematically related to dopamine (DA) levels in the core but not the shell. In the location recognition task, sham-operated animals readily detected the object displacement at test. In the lesion groups, performance impairment was systematically related to DA levels in the shell but not the core. These results suggest that dopamine function within distinct subregions of the NAc plays dissociable roles in the modulation of memory for objects and place.


Assuntos
Dopamina/metabolismo , Rememoração Mental/fisiologia , Núcleo Accumbens/fisiologia , Reconhecimento Psicológico/fisiologia , Análise de Variância , Animais , Masculino , Rememoração Mental/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Neurônios/fisiologia , Núcleo Accumbens/efeitos dos fármacos , Especificidade de Órgãos , Oxidopamina/farmacologia , Ratos , Ratos Wistar , Reconhecimento Psicológico/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...